Monopril 20 mg tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

monopril 20 mg tablete

bausch health ireland limited, 3013 lake drive, citywest business campus, dublin 24, irska - fosinoprilnatrij - tableta - 20 mg - urbroj: jedna tableta sadrži 20 mg fosinoprilnatrija

Monopril plus 20 mg/12,5 mg tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

monopril plus 20 mg/12,5 mg tablete

bausch health ireland limited, 3013 lake drive, citywest business campus, dublin 24, irska - fosinoprilnatrij hidroklorotiazid - tableta - 20 mg + 12,5 mg - urbroj: 1 tableta sadrži 20 mg fosinoprilnatrija i 12,5 mg hidroklorotiazida

Hulio Europska Unija - hrvatski - EMA (European Medicines Agency)

hulio

biosimilar collaborations ireland limited - adalimumab - hidradenitis suppurativa; psoriasis; uveitis; arthritis, rheumatoid; spondylitis, ankylosing; crohn disease; colitis, ulcerative; arthritis, psoriatic - imunosupresivima, faktor nekroze tumora alfa (tnf-α) inhibitori

Deksmedetomidin Mylan 100 mikrograma/ml koncentrat za otopinu za infuziju Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

deksmedetomidin mylan 100 mikrograma/ml koncentrat za otopinu za infuziju

mylan ireland limited, unit 35/36 grange parade, baldoyle industrial estate, dublin 13, irska - deksmedetomidinklorid - koncentrat za otopinu za infuziju - 100 mikrograma/ml - urbroj: jedan ml koncentrata sadrži deksmedetomidinklorid u količini koja odgovara 100 mikrograma deksmedetomidina

Dinuve 2 mg tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

dinuve 2 mg tablete

mylan ireland limited, unit 35/36 grange parade, baldoyle industrial estate, dublin 13, irska - dienogest - tableta - 2 mg - urbroj: jedna tableta sadrži 2 mg dienogesta

Azacitidine Mylan Europska Unija - hrvatski - EMA (European Medicines Agency)

azacitidine mylan

mylan ireland limited - azacitidin - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - antineoplastična sredstva - azacitidine mylan is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with:intermediate 2 and high risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29% marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30% blasts and multi lineage dysplasia, according to world health organisation (who) classification,aml with > 30% marrow blasts according to the who classification.

Sitagliptin / Metformin hydrochloride Mylan Europska Unija - hrvatski - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride mylan

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. trostruki kombinovanu terapiju) kao dodatak prehrani i vježbe kod pacijenata, nedovoljno kontroliranim o njihovo maksimalno переносимой doze метформина i sulfonilurejom. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Novapio 15 mg tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

novapio 15 mg tablete

novatin limited, 230, second floor, eucharistic congress road, mosta, malta - pioglitazonklorid - tableta - 15 mg - urbroj: jedna tableta sadrži 15 mg pioglitazona (u obliku klorida)

Novapio 30 mg tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

novapio 30 mg tablete

novatin limited, 230, second floor, eucharistic congress road, mosta, malta - pioglitazonklorid - tableta - 30 mg - urbroj: jedna tableta sadrži 30 mg pioglitazona (u obliku klorida)

Novapio 45 mg tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

novapio 45 mg tablete

novatin limited, 230, second floor, eucharistic congress road, mosta, malta - pioglitazonklorid - tableta - 45 mg - urbroj: jedna tableta sadrži 45 mg pioglitazona (u obliku klorida)